Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-21
2006-03-21
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S310000, C544S311000, C544S312000
Reexamination Certificate
active
07015230
ABSTRACT:
The invention relates to substituted polycyclic aryl and heteroaryl uracil compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
REFERENCES:
patent: 4489096 (1984-12-01), Terao et al.
patent: 4851413 (1989-07-01), Terao et al.
patent: 4992469 (1991-02-01), Ozawa et al.
patent: 5008267 (1991-04-01), Katakami et al.
patent: 5304658 (1994-04-01), Terao et al.
patent: 5441960 (1995-08-01), Bernstein et al.
patent: 5656645 (1997-08-01), Tamura et al.
patent: 5658930 (1997-08-01), Tamura et al.
patent: 5668289 (1997-09-01), Sanderson et al.
patent: 5741819 (1998-04-01), Illig et al.
patent: 5792779 (1998-08-01), Sanderson et al.
patent: 5861380 (1999-01-01), Gyorkos et al.
patent: 5866573 (1999-02-01), Sanderson et al.
patent: 5869487 (1999-02-01), Coburn et al.
patent: 5872138 (1999-02-01), Naylor-Olsen et al.
patent: 6011158 (2000-01-01), Tamura et al.
patent: 6037356 (2000-03-01), Lu et al.
patent: 6180627 (2001-01-01), Blagg et al.
patent: 6458952 (2002-10-01), South et al.
patent: 6716838 (2004-04-01), South et al.
patent: 2003/0023086 (2003-01-01), South et al.
patent: 198 51 421 (2000-05-01), None
patent: 0 354 495 (1990-02-01), None
patent: 826 671 (1998-03-01), None
patent: 936 216 (1999-08-01), None
patent: 940 400 (1999-09-01), None
patent: 997 474 (2000-05-01), None
patent: 528 633 (2000-10-01), None
patent: WO 93/21214 (1993-10-01), None
patent: WO 96/18644 (1996-06-01), None
patent: WO 96/33974 (1996-10-01), None
patent: WO 96/39380 (1996-12-01), None
patent: WO 96/40100 (1996-12-01), None
patent: WO 97/01338 (1997-01-01), None
patent: WO 97/30708 (1997-08-01), None
patent: WO 97/40024 (1997-10-01), None
patent: WO 97/46207 (1997-12-01), None
patent: WO 98/08840 (1998-03-01), None
patent: WO 98/09949 (1998-03-01), None
patent: WO 98/09987 (1998-03-01), None
patent: WO 98/10763 (1998-03-01), None
patent: WO 98/16525 (1998-04-01), None
patent: WO 98/16547 (1998-04-01), None
patent: WO 98/17274 (1998-04-01), None
patent: WO 98/31670 (1998-07-01), None
patent: WO 98/42342 (1998-10-01), None
patent: WO 98/47876 (1998-10-01), None
patent: WO 98/50420 (1998-11-01), None
patent: WO 99/00121 (1999-01-01), None
patent: WO 99/00126 (1999-01-01), None
patent: WO 99/00128 (1999-01-01), None
patent: WO 99/11267 (1999-03-01), None
patent: WO 99/26920 (1999-06-01), None
patent: WO 99/26926 (1999-06-01), None
patent: WO 99/36426 (1999-07-01), None
patent: WO 99/43660 (1999-09-01), None
patent: WO 99/48892 (1999-09-01), None
patent: WO 99/59591 (1999-11-01), None
patent: WO 99/61442 (1999-12-01), None
patent: WO 99/62538 (1999-12-01), None
patent: WO 99/64446 (1999-12-01), None
patent: WO 00/18762 (2000-04-01), None
patent: WO 00/26210 (2000-05-01), None
patent: WO 00/26211 (2000-05-01), None
patent: WO 00/32574 (2000-06-01), None
patent: WO 00/39102 (2000-07-01), None
patent: WO 00/69826 (2000-11-01), None
patent: WO 00/69832 (2000-11-01), None
patent: WO 00/69833 (2000-11-01), None
Hart et al., Atrial Fibrillation and Thromboembolism: A decade of progress in Stroke Prevention, Ann. Intern. Med. vol. 131, No. 9, pp. 688-695, 1999.
Rauch et al., Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences, Annals of Internal Medicine, vol. 134, No. 3, pp. 224-233, 2001.
VanAken et al., Anticoagulation: The Present and Future, Clin. Appl. Thrombosis/Hemostasis, 7(3), pp. 195-204, 2001.
Majerus, et al. “Anticoagulant, Thrombolytic, and Antiplatelet Drugs.” Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition, 1996, pp. 1341-1359, McGraw-Hill, New York.
Handin, R., “Bleeding and Thrombosis.” Harrison's Principles of Internal Medicine, 12th Edition, 1991, pp. 348-353, McGraw-Hill, Inc., New York.
Sanderson, et al., “L-373,890, An Achiral, Noncovalent, Subnanomolar Thrombin Inhibitor.” Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 12, pp 1497-1500, 1997.
Coburn, C.A., “Small-moleclule direct thrombine inhibitors 1997-2000.” Expert Opinions on Therapeutic Patents, 2001, 721-738, vol. 11, No. 5.
XP-002182132—Darvas, et al., “Investigation of the Common Mechanism of Action of Antibacterial Compounds Containing .gamma.-pyridone-.beta.-carboxylic acid Structure by Principal Component.” Arzneim.-Forsch., 1979, pp. 1334-1339, vol. 29, 9.
XP-002172033—Kohama et al., “Preparation of Piperidinyloxyacetylaminobenzoytalanine Derivatives and Analogs as Antithrombotics.” JP 07,233,148.
XP-002187583—Moerner, Hoppe-Seyler's Z. Physiol. Chem., 69, 1910; 357.
Patel et al., “Directed Aminomethylation of 3-Hydroxy-3(1H)-pyridinones and 3-hydroxy-4(1H)-pyridinones: Synthesis of iso-Deferiprone.” Tetrahedron, 1996, pp. 1835-1840, vol. 52, No. 5.
XP-002182410—Trecourt et al., “First Synthesis of (+−)-harzianopyridone by Metalation of Polysubsituted O-pyridylcarbamates.” J. Heterocycl. Chem., 1995, pp. 1117-1114, vol. 32, No. 4.
Tulinsky et al., “Novel Asymmetric Synthesis of Atropisomeric 6-Aryl Pyrazinones via an Unusual Chirality Transfer Process.” J. Org. Chem., 1999, pp. 93-100, vol. 64, No. 1.
Jones Darin E.
Rueppel Melvin L.
South Michael S.
Pharmacia Corporation
Rao Deepak
LandOfFree
Substituted polycyclic aryl and heteroaryl uracils useful... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted polycyclic aryl and heteroaryl uracils useful..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted polycyclic aryl and heteroaryl uracils useful... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3531563